AKT1 and non-small cell lung carcinoma: For example, SLC1A3 modulates the PI3K/AKT pathway, which facilitates gastric cancer progression34, while LncRNA HAND2-AS1 suppresses the PI3K/Akt pathway in non-small-cell lung cancer.